期刊
ENDOCRINE-RELATED CANCER
卷 24, 期 9, 页码 T107-T117出版社
BIOSCIENTIFICA LTD
DOI: 10.1530/ERC-17-0120
关键词
taxane; vinca alkaloids; castration-resistant prostate cancer; triple-negative breast cancer; mitosis; spindle assembly checkpoint; WEE1 inhibitor; MYT1
资金
- AIRC, Associazione Italiana per la Ricerca sul Cancro
Tubulin-targeting drugs, like taxanes and vinca alkaloids, are among the most effective anticancer therapeutics used in the clinic today. Specifically, anti-microtubule cancer drugs (AMCDs) have proven to be effective in the treatment of castration-resistant prostate cancer and triple-negative breast cancer. AMCDs, however, have limiting toxicities that include neutropenia and neurotoxicity, and, in addition, tumor cells can become resistant to the drugs after long-term use. Co-targeting mitotic progression/slippage with inhibition of the protein kinases WEE1 and MYT1 that regulate CDK1 kinase activity may improve AMCD efficacy, reducing the acquisition of resistance by the tumor and side effects from the drug and/or its vehicle. Other possible treatments that improve outcomes in the clinic for these two drug-resistant cancers, including new formulations of the AMCDs and pursuing different molecular targets, will be discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据